Lexicon Pharmaceuticals to Report First Quarter 2025 Financial Results on May 13, 2025
Lexicon Pharmaceuticals (NASDAQ: LXRX) has scheduled its first quarter 2025 financial results announcement for Tuesday, May 13, 2025, after market close. The company will host a conference call and live webcast at 5:00 p.m. ET (4:00 p.m. CT) on the same day, where management will discuss the quarterly results and provide a business update. Interested participants can access the webcast through the Events page on Lexicon's investor website, while those wishing to ask questions during the call can register to receive dial-in information. An archived version of the webcast will be made available on the company's website for later viewing.
Lexicon Pharmaceuticals (NASDAQ: LXRX) ha programmato l'annuncio dei risultati finanziari del primo trimestre 2025 per martedì 13 maggio 2025, dopo la chiusura del mercato. La società terrà una conference call e una diretta webcast alle 17:00 ET (16:00 CT) dello stesso giorno, durante le quali il management discuterà i risultati trimestrali e fornirà un aggiornamento sul business. I partecipanti interessati potranno accedere alla webcast tramite la pagina Eventi del sito web per gli investitori di Lexicon, mentre chi desidera porre domande durante la chiamata può registrarsi per ricevere le informazioni di accesso. Una versione archiviata della webcast sarà disponibile sul sito aziendale per la visione successiva.
Lexicon Pharmaceuticals (NASDAQ: LXRX) ha programado el anuncio de sus resultados financieros del primer trimestre de 2025 para el martes 13 de mayo de 2025, después del cierre del mercado. La compañía realizará una llamada conferencia y una transmisión en vivo a las 5:00 p.m. ET (4:00 p.m. CT) el mismo día, donde la dirección discutirá los resultados trimestrales y ofrecerá una actualización del negocio. Los interesados pueden acceder a la transmisión a través de la página de Eventos en el sitio web para inversores de Lexicon, y quienes deseen hacer preguntas durante la llamada pueden registrarse para recibir la información de acceso. Una versión archivada de la transmisión estará disponible en el sitio web de la empresa para su visualización posterior.
Lexicon Pharmaceuticals (NASDAQ: LXRX)는 2025년 1분기 재무 실적 발표를 2025년 5월 13일 화요일, 시장 마감 후에 예정하고 있습니다. 회사는 같은 날 오후 5시 ET(오후 4시 CT)에 컨퍼런스 콜과 라이브 웹캐스트를 진행하며, 경영진이 분기 실적을 논의하고 사업 현황을 업데이트할 예정입니다. 관심 있는 참가자는 Lexicon 투자자 웹사이트의 이벤트 페이지를 통해 웹캐스트에 접속할 수 있으며, 통화 중 질문을 원하는 경우 등록하여 전화 접속 정보를 받을 수 있습니다. 웹캐스트 녹화본은 회사 웹사이트에 아카이브되어 나중에 시청할 수 있습니다.
Lexicon Pharmaceuticals (NASDAQ : LXRX) a programmé l'annonce de ses résultats financiers du premier trimestre 2025 pour le mardi 13 mai 2025, après la clôture du marché. La société organisera une conférence téléphonique et une diffusion en direct à 17h00 ET (16h00 CT) le même jour, au cours desquelles la direction discutera des résultats trimestriels et fournira une mise à jour sur l'activité. Les participants intéressés pourront accéder à la diffusion via la page Événements du site investisseurs de Lexicon, tandis que ceux souhaitant poser des questions pendant l'appel peuvent s'inscrire pour recevoir les informations de connexion. Une version archivée de la diffusion sera disponible sur le site de la société pour une consultation ultérieure.
Lexicon Pharmaceuticals (NASDAQ: LXRX) hat die Bekanntgabe der Finanzergebnisse für das erste Quartal 2025 für Dienstag, den 13. Mai 2025, nach Börsenschluss geplant. Das Unternehmen wird am selben Tag um 17:00 Uhr ET (16:00 Uhr CT) eine Telefonkonferenz und eine Live-Webcast veranstalten, bei der das Management die Quartalsergebnisse besprechen und ein Geschäftsupdate geben wird. Interessierte Teilnehmer können über die Veranstaltungsseite auf der Investorenseite von Lexicon auf den Webcast zugreifen. Wer während des Anrufs Fragen stellen möchte, kann sich registrieren, um die Einwahlinformationen zu erhalten. Eine archivierte Version des Webcasts wird später auf der Unternehmenswebsite verfügbar sein.
- None.
- None.
THE WOODLANDS, Texas, May 06, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced the Company will release its first quarter 2025 financial results on Tuesday, May 13, 2025, after the markets close. Management will conduct a conference call and live webcast at 5:00 p.m. ET (4:00 p.m. CT) that day to discuss the financial results and to provide a business update.
Participants can access the conference call live via webcast on the Events page of the Company’s website at https://investors.lexpharma.com/. Participants who wish to ask a question may register here to receive dial-in numbers and a unique pin to join the call. An archived version of the webcast will be available on the Lexicon website.
About Lexicon Pharmaceuticals
Lexicon is a biopharmaceutical company with a mission of pioneering medicines that transform patients’ lives. Through the Genome5000™ program, Lexicon’s unique genomics target discovery platform, Lexicon scientists studied the role and function of nearly 5,000 genes and identified more than 100 protein targets with significant therapeutic potential in a range of diseases. Through the precise targeting of these proteins, Lexicon is pioneering the discovery and development of innovative medicines to safely and effectively treat disease. Lexicon has advanced multiple medicines to market and has a pipeline of promising drug candidates in discovery and clinical and preclinical development in heart failure, neuropathic pain, obesity, cardiology, diabetes and other indications. For additional information, please visit www.lexpharma.com.
For Investor and Media Inquiries:
Lisa DeFrancesco
Lexicon Pharmaceuticals, Inc.
lexinvest@lexpharma.com
FAQ
When will Lexicon Pharmaceuticals (LXRX) report Q1 2025 earnings?
What time is Lexicon Pharmaceuticals' Q1 2025 earnings call?
How can investors access Lexicon Pharmaceuticals' Q1 2025 earnings call?
Will Lexicon's Q1 2025 earnings call be available for replay?
